Brugarolas A - Search Results

1

Prospective and controlled studies on multidisciplinary treatment in gastrointestinal cancer.

Gérard A, Gignoux M, Roussel A, Goffin JC, Brugarolas A, Zeitoun P, Martin F, Buyse M, Duez N. Gérard A, et al. Among authors: brugarolas a. Recent Results Cancer Res. 1981;79:19-27. doi: 10.1007/978-3-642-81681-9_3. Recent Results Cancer Res. 1981. PMID: 7029682 Clinical Trial. No abstract available.

2

Preliminary clinical results with norgamem (thioproline) and revercan (2-amino-2-thiazoline): the first inducers of reverse transformation.

Brugarolas A, Gosálvez M. Brugarolas A, et al. Recent Results Cancer Res. 1982;80:346-50. doi: 10.1007/978-3-642-81685-7_56. Recent Results Cancer Res. 1982. PMID: 7036296 Clinical Trial. No abstract available.

3

Quelamycin: a summary of phase I clinical trials.

Cortés-Funes H, Brugarolas A, Gosálvez M. Cortés-Funes H, et al. Among authors: brugarolas a. Recent Results Cancer Res. 1980;74:200-6. doi: 10.1007/978-3-642-81488-4_25. Recent Results Cancer Res. 1980. PMID: 7444140

4

Results of two sequential chemotherapy studies in WHO Types I, III and IV lung cancer: cyclophosphamide-5-fluorouracil (CF) and cyclophosphamide-5-fluorouracil-adriamycin (CAF).

Brugarolas A, Lacave AJ, Ribas A, Buesa JM, Garcia Miralles MT. Brugarolas A, et al. Eur J Cancer (1965). 1979 Mar;15(3):331-5. doi: 10.1016/0014-2964(79)90044-6. Eur J Cancer (1965). 1979. PMID: 376316 Clinical Trial. No abstract available.

5

Treatment of cancer by an inducer of reverse transformation.

Brugarolas A, Gosalvez M. Brugarolas A, et al. Lancet. 1980 Jan 12;1(8159):68-70. doi: 10.1016/s0140-6736(80)90494-8. Lancet. 1980. PMID: 6101417

6

Phase I clinical study of quelamycin.

Brugarolas A, Pachon N, Gosalvez M, Llanderal AP, Lacave AJ, Buesa JM, Marco MG. Brugarolas A, et al. Cancer Treat Rep. 1978 Oct;62(10):1527-34. Cancer Treat Rep. 1978. PMID: 361226 Clinical Trial.

7

Vincristine (NSC 67574) in non-small cell bronchogenic carcinoma. Results of a phase II clinical study.

Brugarolas A, Lacave AJ, Ribas A, Miralles MT. Brugarolas A, et al. Eur J Cancer (1965). 1978 May;14(5):501-5. doi: 10.1016/0014-2964(78)90252-9. Eur J Cancer (1965). 1978. PMID: 348479 Clinical Trial. No abstract available.

8

5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study.

Brugarolas A, Rivas A, Lacave AJ, Gonzalez-Palacois F, Froufe A. Brugarolas A, et al. Cancer Chemother Rep. 1975 Sep-Oct;59(5):1025-6. Cancer Chemother Rep. 1975. PMID: 1106844 Clinical Trial. No abstract available.

9

Iron toxicity studies of quelamycin.

Brugarolas A, Perez Llanderal JA, Garcia Miralles MT, Lacave AJ, Gracia Marco M, Izquierdo JM, Rodriguez Llorian AC, Ribas A. Brugarolas A, et al. Cancer Treat Rep. 1979 May;63(5):909-13. Cancer Treat Rep. 1979. PMID: 455332

10

Phase I and II clinical study of anhydro-ara-5-fluorocytosine (AAFC) and ICRF-159 combination in adenocarcinoma of digestive origin.

Brugarolas A, Buesa JM, Lacave AJ, Gracia Marco M, Valle Pereda M. Brugarolas A, et al. Cancer Clin Trials. 1978 Winter;1(4):289-95. Cancer Clin Trials. 1978. PMID: 93030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters